Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05107427
Title Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma (AVENU)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors 4D pharma plc
Indications

transitional cell carcinoma

Therapies

Avelumab + MRx0518

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.